Whanin Pharm Co (XKRX:016580) ROCE % : 12.25% (As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Whanin Pharm Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Whanin Pharm Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 12.25%.

Whanin Pharm Co ROCE % Historical Data

The historical data trend for Whanin Pharm Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Whanin Pharm Co ROCE % Chart

Whanin Pharm Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

10.38

10.67

10.86

9.05

9.68

Whanin Pharm Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															10.65	10.97	9.22	8.09	12.25

Whanin Pharm Co ROCE % Calculation

Whanin Pharm Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	33815.968	/	( ( (369374.561 - 31750.48)	+	(401226.633 - 40027.751) )	/ 2 )
	=	33815.968	/	( (337624.081	+	361198.882)	/ 2 )
	=	33815.968	/	349411.4815
	=	9.68 %

Whanin Pharm Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	44531.792	/	( ( (401226.633 - 40027.751)	+	(415529.99 - 49719.66) )	/ 2 )
	=	44531.792	/	( ( 361198.882	+	365810.33 )	/ 2 )
	=	44531.792	/	363504.606
	=	12.25 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Whanin Pharm Co (XKRX:016580) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Whanin Pharm Co ROCE % Related Terms

Thank you for viewing the detailed overview of Whanin Pharm Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Whanin Pharm Co (XKRX:016580) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Whanin Pharm Co Ltd (XKRX:016580) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

84-1 Munjeong-dong, Songpa-gu, Seoul, KOR, 138-200

Website

http://www.whanin.co.kr

Whanin Pharm Co Ltd is a pharmaceutical company. The company develops, manufactures, markets, and sells the therapeutic products. It offers antibiotics, cardiovascular drugs, CNS stimulants, gastrointestinal drugs, multivitamins and other products. The company's products include Antiasthmatics; Antidepressants; Antipsychotics; Anxiolytics and hypnotics; and Antiepileptics.

Whanin Pharm Co (XKRX:016580) Headlines

No Headlines